Cancer combined modality therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured MCF-7 Cells HCT116 Cells HT29 Cells Lymph Nodes Cell Line Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases53

Hodgkin Disease Lung Neoplasms Carcinoma, Small Cell Carcinoma, Non-Small-Cell Lung Adenocarcinoma Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Carcinoma Disease Progression Urinary Bladder Neoplasms Colorectal Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Liver Neoplasms Head and Neck Neoplasms Bone Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Second Primary Neoplasms, Radiation-Induced Neovascularization, Pathologic Skin Neoplasms Gastrointestinal Neoplasms Neoplasms, Glandular and Epithelial Genital Neoplasms, Female Precancerous Conditions Thyroid Neoplasms Disease Models, Animal Mammary Neoplasms, Experimental Neoplasms, Multiple Primary Pharyngeal Neoplasms Melanoma Kidney Neoplasms Brain Neoplasms Neoplasms, Experimental Breast Neoplasms, Male Carcinoma, Lobular Testicular Neoplasms Neoplastic Syndromes, Hereditary Carcinoma in Situ

Chemicals and Drugs55

Mechlorethamine Procarbazine Lomustine Vincristine Prednisone Cisplatin Cyclophosphamide Fluorouracil Doxorubicin Cancer Vaccines Neoplasm Proteins Antineoplastic Agents Tumor Markers, Biological Receptors, Estrogen RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen RNA, Small Interfering DNA, Neoplasm Tumor Suppressor Protein p53 Tamoxifen Antigens, Neoplasm Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Receptors, Progesterone Paclitaxel Antibodies, Monoclonal Anticarcinogenic Agents Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Deoxycytidine Antimetabolites, Antineoplastic Radiopharmaceuticals Receptors, Androgen Taxoids Antibodies, Monoclonal, Humanized RNA, Neoplasm DNA-Binding Proteins Androgens BRCA2 Protein Proto-Oncogene Proteins Transcription Factors Estrogens Proto-Oncogene Proteins c-akt Nuclear Proteins BRCA1 Protein Carcinogens Protein Kinase Inhibitors Carcinoembryonic Antigen Androgen Antagonists Quinazolines Estrogen Receptor alpha Organoplatinum Compounds Antibiotics, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Radiotherapy Radiotherapy Dosage Actuarial Analysis Survival Analysis Neoplasm Staging Prognosis Radiotherapy, Adjuvant Survival Rate Chemotherapy, Adjuvant Early Detection of Cancer Disease-Free Survival Clinical Trials as Topic Follow-Up Studies Treatment Outcome Retrospective Studies Prospective Studies Risk Sensitivity and Specificity Reverse Transcriptase Polymerase Chain Reaction Registries Xenograft Model Antitumor Assays Risk Assessment Gene Expression Profiling Neoplasm Transplantation Blotting, Western Odds Ratio Reproducibility of Results Tomography, X-Ray Computed Risk Factors Diagnostic Imaging Transplantation, Heterologous Mammography Predictive Value of Tests Multivariate Analysis Kaplan-Meier Estimate Questionnaires Tumor Burden Oligonucleotide Array Sequence Analysis Molecular Targeted Therapy SEER Program Positron-Emission Tomography Drug Screening Assays, Antitumor Magnetic Resonance Imaging Polymerase Chain Reaction Logistic Models Models, Biological Transfection Neoplasm Grading Confidence Intervals Incidence Tissue Array Analysis Immunotherapy Palliative Care Biopsy Flow Cytometry Disease Models, Animal Mammary Neoplasms, Experimental Gene Knockdown Techniques Immunoenzyme Techniques Mastectomy Genetic Therapy Drug Delivery Systems Drug Administration Schedule Colonoscopy Prostatectomy Genetic Testing Neoplasms, Experimental Immunohistochemistry DNA Mutational Analysis Feasibility Studies Cohort Studies Pilot Projects Lymph Node Excision Analysis of Variance

Psychiatry and Psychology1

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Sensitivity and Specificity Mutation Odds Ratio Cell Survival DNA Methylation Cell Movement Genotype Down-Regulation Genes, BRCA1 Apoptosis Cell Division Dose-Response Relationship, Drug Cell Proliferation Cell Cycle Polymorphism, Genetic Cell Growth Processes Promoter Regions, Genetic RNA Interference Transfection Up-Regulation Gene Silencing Time Factors Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Genes, p53 Base Sequence Signal Transduction Postmenopause Gene Expression Phenotype Diet Genes, BRCA2 Phosphorylation Drug Synergism Algorithms Alleles Epithelial-Mesenchymal Transition Tumor Microenvironment Epigenesis, Genetic Menopause Premenopause

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Questionnaires SEER Program Incidence Base Sequence Molecular Sequence Data Algorithms

Named Groups2

Survivors European Continental Ancestry Group

Health Care34

Actuarial Analysis Survival Analysis Survival Rate Disease-Free Survival Clinical Trials as Topic Follow-Up Studies Treatment Outcome Retrospective Studies Prospective Studies Risk Sensitivity and Specificity Registries National Cancer Institute (U.S.)Risk Assessment Age Factors Odds Ratio Reproducibility of Results Risk Factors Predictive Value of Tests Multivariate Analysis Kaplan-Meier Estimate Questionnaires SEER Program Logistic Models American Cancer Society Confidence Intervals Incidence Palliative Care Genetic Testing Age Distribution Feasibility Studies Cohort Studies Pilot Projects Analysis of Variance

Geographicals5

United States Japan China Sweden Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Combined Modality Therapy Mechlorethamine Procarbazine Hodgkin Disease Lomustine Antineoplastic Combined Chemotherapy Protocols Radiotherapy Vincristine Radiotherapy Dosage Lung Neoplasms Prednisone Actuarial Analysis Carcinoma, Small Cell Survival Analysis Neoplasm Staging Prognosis Radiotherapy, Adjuvant Survival Rate Cisplatin Cyclophosphamide Chemotherapy, Adjuvant Carcinoma, Non-Small-Cell Lung Early Detection of Cancer Disease-Free Survival Clinical Trials as Topic Follow-Up Studies Adenocarcinoma Fluorouracil Treatment Outcome Doxorubicin Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Mice, Nude Cancer Vaccines Gene Expression Regulation, Neoplastic Retrospective Studies Neoplasm Proteins Antineoplastic Agents Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Prospective Studies Carcinoma Cell Line, Tumor Disease Progression Drug Resistance, Neoplasm Urinary Bladder Neoplasms Risk Colorectal Neoplasms Sensitivity and Specificity Reverse Transcriptase Polymerase Chain Reaction Registries National Cancer Institute (U.S.)Xenograft Model Antitumor Assays Neoplasm Recurrence, Local Risk Assessment Tumor Markers, Biological Gene Expression Profiling Receptors, Estrogen United States Rectal Neoplasms Mutation Survivors RNA, Messenger Receptor, erbB-2 Neoplasm Transplantation Age Factors Prostate-Specific Antigen Blotting, Western Odds Ratio Endometrial Neoplasms RNA, Small Interfering Cell Transformation, Neoplastic DNA, Neoplasm Esophageal Neoplasms Reproducibility of Results Tomography, X-Ray Computed Medical Oncology Cell Survival Risk Factors Liver Neoplasms Diagnostic Imaging DNA Methylation Transplantation, Heterologous Smoking Mammography Tumor Suppressor Protein p53 Tamoxifen Predictive Value of Tests Head and Neck Neoplasms Multivariate Analysis Kaplan-Meier Estimate Neoplastic Stem Cells

No FAQ available that match "cancer combined modality therapy"